Revolade TM
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional. Always read the label. If symptoms persist see your healthcare professional.
Active ingredients: eltrombopag
Brand name
(ARTG)
: REVOLADE eltrombopag 50mg film-coated tablet blister packDownload the Consumer Medicine Information Leaflet
Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website
What this medicine is used for
(ARTG)
REVOLADE is indicated for the treatment of: - paediatric patients with chronic immune thrombocytopaenia (ITP) who have failed other treatments and either (a) need an increased platelet concentration for a planned procedure or (b) are at a high risk of bleeding.,- adult patients with ITP who have had an inadequate response or are intolerant to corticosteroids and immunoglobulins.,- thrombocytopenia in adult patients with chronic hepatitis C to allow the initiation and maintenance of interferon-based therapy.,- severe aplastic anaemia (SAA) in combination with standard immunosuppressive therapy for the first-line treatment of adult and paediatric patients 2 years and older.,- adult patients with SAA who have had an insufficient response to immunosuppressive therapy.
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Tablet, film coated
- Oral
- Round, biconvex, brown, and film-coated, debossed with "GS UFU" and "50" on one side.
Storage conditions
(ARTG)
- Store below 30 degrees Celsius
- See Product information for shelf life
- Shelf lifetime is 36 Months.
Do I need a prescription ?
(ARTG)
These medicine packs are available from a pharmacist and requires a prescription. It is Schedule 4 : Prescription Only Medicine.
- 14 pack
- 28 pack
- 84 pack
Is this medicine subsidised ?
(PBS)
This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on November, 1 2024. To learn more about this subsidy, visit the Pharmaceutical Benefits Scheme (PBS) website.
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient eltrombopag
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
Brand name
(ARTG)
: REVOLADE eltrombopag 25mg film-coated tablet blister packDownload the Consumer Medicine Information Leaflet
Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website
What this medicine is used for
(ARTG)
REVOLADE is indicated for the treatment of: - paediatric patients with chronic immune thrombocytopaenia (ITP) who have failed other treatments and either (a) need an increased platelet concentration for a planned procedure or (b) are at a high risk of bleeding.,- adult patients with ITP who have had an inadequate response or are intolerant to corticosteroids and immunoglobulins.,- thrombocytopenia in adult patients with chronic hepatitis C to allow the initiation and maintenance of interferon-based therapy.,- severe aplastic anaemia (SAA) in combination with standard immunosuppressive therapy for the first-line treatment of adult and paediatric patients 2 years and older.,- adult patients with SAA who have had an insufficient response to immunosuppressive therapy.
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Tablet, film coated
- Oral
- Round, biconvex, white, and film-coated, debossed with "GS NX3" and "25" on one side.
Storage conditions
(ARTG)
- Store below 30 degrees Celsius
- See Product information for shelf life
- Shelf lifetime is 36 Months.
Do I need a prescription ?
(ARTG)
These medicine packs are available from a pharmacist and requires a prescription. It is Schedule 4 : Prescription Only Medicine.
- 14 pack
- 28 pack
- 84 pack
Is this medicine subsidised ?
(PBS)
This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on November, 1 2024. To learn more about this subsidy, visit the Pharmaceutical Benefits Scheme (PBS) website.
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient eltrombopag
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
Brand name
(ARTG)
: REVOLADE eltrombopag 75mg film-coated tablet blister packWhat this medicine is used for
(ARTG)
REVOLADE is indicated for the treatment of: - paediatric patients with chronic immune thrombocytopaenia (ITP) who have failed other treatments and either (a) need an increased platelet concentration for a planned procedure or (b) are at a high risk of bleeding.,- adult patients with ITP who have had an inadequate response or are intolerant to corticosteroids and immunoglobulins.,- thrombocytopenia in adult patients with chronic hepatitis C to allow the initiation and maintenance of interferon-based therapy.,- severe aplastic anaemia (SAA) in combination with standard immunosuppressive therapy for the first-line treatment of adult and paediatric patients 2 years and older.,- adult patients with SAA who have had an insufficient response to immunosuppressive therapy.
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Tablet, film coated
- Oral
- Pink round, biconvex film coated tablet, debossed with 'GS FFS' and '75' on one side
Storage conditions
(ARTG)
- Store below 30 degrees Celsius
- See Product information for shelf life
- Shelf lifetime is 36 Years.
Do I need a prescription ?
(ARTG)
These medicine packs are available from a pharmacist and requires a prescription. It is Schedule 4 : Prescription Only Medicine.
- 14 pack
- 28 pack
- 84 pack
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient eltrombopag
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
Brand name
(ARTG)
: REVOLADE eltrombopag 12.5mg film-coated tablet blister packWhat this medicine is used for
(ARTG)
REVOLADE is indicated for the treatment of: - paediatric patients with chronic immune thrombocytopaenia (ITP) who have failed other treatments and either (a) need an increased platelet concentration for a planned procedure or (b) are at a high risk of bleeding.,- adult patients with ITP who have had an inadequate response or are intolerant to corticosteroids and immunoglobulins.,- thrombocytopenia in adult patients with chronic hepatitis C to allow the initiation and maintenance of interferon-based therapy.,- severe aplastic anaemia (SAA) in combination with standard immunosuppressive therapy for the first-line treatment of adult and paediatric patients 2 years and older.,- adult patients with SAA who have had an insufficient response to immunosuppressive therapy.
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Tablet, film coated
- Oral
- White, round, biconvex, film-coated tablets (approximately 7.9 mm in diameter), debossed with "GS MZ1" and "12.5" on one side.
Storage conditions
(ARTG)
- Store below 30 degrees Celsius
- See Product information for shelf life
- Shelf lifetime is 36 Months.
Do I need a prescription ?
(ARTG)
These medicine packs are available from a pharmacist and requires a prescription. It is Schedule 4 : Prescription Only Medicine.
- 14 pack
- 28 pack
- 84 pack
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient eltrombopag
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
Brand name
(ARTG)
: REVOLADE eltrombopag 12.5mg film-coated tablet blister packWhat this medicine is used for
(ARTG)
REVOLADE is indicated for the treatment of: - paediatric patients with chronic immune thrombocytopaenia (ITP) who have failed other treatments and either (a) need an increased platelet concentration for a planned procedure or (b) are at a high risk of bleeding.,- adult patients with ITP who have had an inadequate response or are intolerant to corticosteroids and immunoglobulins.,- thrombocytopenia in adult patients with chronic hepatitis C to allow the initiation and maintenance of interferon-based therapy.,- severe aplastic anaemia (SAA) in combination with standard immunosuppressive therapy for the first-line treatment of adult and paediatric patients 2 years and older.,- adult patients with SAA who have had an insufficient response to immunosuppressive therapy.
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Tablet, film coated
- Oral
- White, round, biconvex, film-coated tablets (approximately 7.9 mm in diameter), debossed with "GS MZ1" and "12.5" on one side.
Storage conditions
(ARTG)
- Store below 30 degrees Celsius
- See Product information for shelf life
- Shelf lifetime is 36 Months.
Do I need a prescription ?
(ARTG)
These medicine packs are available from a pharmacist and requires a prescription. It is Schedule 4 : Prescription Only Medicine.
- 14 pack
- 28 pack
- 84 pack
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient eltrombopag
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
Brand name
(ARTG)
: REVOLADE eltrombopag 12.5mg film-coated tablet blister packWhat this medicine is used for
(ARTG)
REVOLADE is indicated for the treatment of: - paediatric patients with chronic immune thrombocytopaenia (ITP) who have failed other treatments and either (a) need an increased platelet concentration for a planned procedure or (b) are at a high risk of bleeding.,- adult patients with ITP who have had an inadequate response or are intolerant to corticosteroids and immunoglobulins.,- thrombocytopenia in adult patients with chronic hepatitis C to allow the initiation and maintenance of interferon-based therapy.,- severe aplastic anaemia (SAA) in combination with standard immunosuppressive therapy for the first-line treatment of adult and paediatric patients 2 years and older.,- adult patients with SAA who have had an insufficient response to immunosuppressive therapy.
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Tablet, film coated
- Oral
- White, round, biconvex, film-coated tablets (approximately 7.9 mm in diameter), debossed with "GS MZ1" and "12.5" on one side.
Storage conditions
(ARTG)
- Store below 30 degrees Celsius
- See Product information for shelf life
- Shelf lifetime is 36 Months.
Do I need a prescription ?
(ARTG)
These medicine packs are available from a pharmacist and requires a prescription. It is Schedule 4 : Prescription Only Medicine.
- 14 pack
- 28 pack
- 84 pack
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient eltrombopag
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
Brand name
(ARTG)
: REVOLADE eltrombopag 50mg film-coated tablet blister packDownload the Consumer Medicine Information Leaflet
Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website
What this medicine is used for
(ARTG)
REVOLADE is indicated for the treatment of: - paediatric patients with chronic immune thrombocytopaenia (ITP) who have failed other treatments and either (a) need an increased platelet concentration for a planned procedure or (b) are at a high risk of bleeding.,- adult patients with ITP who have had an inadequate response or are intolerant to corticosteroids and immunoglobulins.,- thrombocytopenia in adult patients with chronic hepatitis C to allow the initiation and maintenance of interferon-based therapy.,- severe aplastic anaemia (SAA) in combination with standard immunosuppressive therapy for the first-line treatment of adult and paediatric patients 2 years and older.,- adult patients with SAA who have had an insufficient response to immunosuppressive therapy.
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Tablet, film coated
- Oral
- Round, biconvex, brown, and film-coated, debossed with "GS UFU" and "50" on one side.
Storage conditions
(ARTG)
- Store below 30 degrees Celsius
- See Product information for shelf life
- Shelf lifetime is 36 Months.
Do I need a prescription ?
(ARTG)
These medicine packs are available from a pharmacist and requires a prescription. It is Schedule 4 : Prescription Only Medicine.
- 14 pack
- 28 pack
- 84 pack
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient eltrombopag
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
Brand name
(ARTG)
: REVOLADE eltrombopag 25mg film-coated tablet blister packDownload the Consumer Medicine Information Leaflet
Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website
What this medicine is used for
(ARTG)
REVOLADE is indicated for the treatment of: - paediatric patients with chronic immune thrombocytopaenia (ITP) who have failed other treatments and either (a) need an increased platelet concentration for a planned procedure or (b) are at a high risk of bleeding.,- adult patients with ITP who have had an inadequate response or are intolerant to corticosteroids and immunoglobulins.,- thrombocytopenia in adult patients with chronic hepatitis C to allow the initiation and maintenance of interferon-based therapy.,- severe aplastic anaemia (SAA) in combination with standard immunosuppressive therapy for the first-line treatment of adult and paediatric patients 2 years and older.,- adult patients with SAA who have had an insufficient response to immunosuppressive therapy.
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Tablet, film coated
- Oral
- Round, biconvex, white, and film-coated, debossed with "GS NX3" and "25" on one side.
Storage conditions
(ARTG)
- Store below 30 degrees Celsius
- See Product information for shelf life
- Shelf lifetime is 36 Months.
Do I need a prescription ?
(ARTG)
These medicine packs are available from a pharmacist and requires a prescription. It is Schedule 4 : Prescription Only Medicine.
- 14 pack
- 28 pack
- 84 pack
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient eltrombopag
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
Brand name
(ARTG)
: REVOLADE eltrombopag 25mg film-coated tablet blister packDownload the Consumer Medicine Information Leaflet
Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website
What this medicine is used for
(ARTG)
REVOLADE is indicated for the treatment of: - paediatric patients with chronic immune thrombocytopaenia (ITP) who have failed other treatments and either (a) need an increased platelet concentration for a planned procedure or (b) are at a high risk of bleeding.,- adult patients with ITP who have had an inadequate response or are intolerant to corticosteroids and immunoglobulins.,- thrombocytopenia in adult patients with chronic hepatitis C to allow the initiation and maintenance of interferon-based therapy.,- severe aplastic anaemia (SAA) in combination with standard immunosuppressive therapy for the first-line treatment of adult and paediatric patients 2 years and older.,- adult patients with SAA who have had an insufficient response to immunosuppressive therapy.
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Tablet, film coated
- Oral
- Round, biconvex, white, and film-coated, debossed with "GS NX3" and "25" on one side.
Storage conditions
(ARTG)
- Store below 30 degrees Celsius
- See Product information for shelf life
- Shelf lifetime is 36 Months.
Do I need a prescription ?
(ARTG)
These medicine packs are available from a pharmacist and requires a prescription. It is Schedule 4 : Prescription Only Medicine.
- 14 pack
- 28 pack
- 84 pack
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient eltrombopag
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
Brand name
(ARTG)
: REVOLADE eltrombopag 50mg film-coated tablet blister packDownload the Consumer Medicine Information Leaflet
Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website
What this medicine is used for
(ARTG)
REVOLADE is indicated for the treatment of: - paediatric patients with chronic immune thrombocytopaenia (ITP) who have failed other treatments and either (a) need an increased platelet concentration for a planned procedure or (b) are at a high risk of bleeding.,- adult patients with ITP who have had an inadequate response or are intolerant to corticosteroids and immunoglobulins.,- thrombocytopenia in adult patients with chronic hepatitis C to allow the initiation and maintenance of interferon-based therapy.,- severe aplastic anaemia (SAA) in combination with standard immunosuppressive therapy for the first-line treatment of adult and paediatric patients 2 years and older.,- adult patients with SAA who have had an insufficient response to immunosuppressive therapy.
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Tablet, film coated
- Oral
- Round, biconvex, brown, and film-coated, debossed with "GS UFU" and "50" on one side.
Storage conditions
(ARTG)
- Store below 30 degrees Celsius
- See Product information for shelf life
- Shelf lifetime is 36 Months.
Do I need a prescription ?
(ARTG)
These medicine packs are available from a pharmacist and requires a prescription. It is Schedule 4 : Prescription Only Medicine.
- 14 pack
- 28 pack
- 84 pack
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient eltrombopag
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
